BARINTHUS BIOTHERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.60 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-06
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $0.60, a 29.41% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-03-31 was $0.85, a 70.69% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-31 was $2.90, a 44.28% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $2.01.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $0.85, a 68.05% decline from fiscal 2024.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $2.66, a 33.67% increase from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.99, a 43.30% decline from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $3.51, a 68.03% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.60 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $0.60 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $0.85 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $0.85 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $0.85 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $0.85 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | $2.66 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $2.71 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $2.71 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $2.90 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $1.99 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $1.99 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $2.00 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $2.01 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | $3.51 10-K · filed 2024-03-20 | |||
| 2021-12-31 | $10.98 10-K · filed 2023-03-24 | |||
| 2020-12-31 | $5.66 10-K · filed 2022-03-25 |